China Universal Asset Management Co., Ltd. Madrigal Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 4,176 shares of MDGL stock, worth $906,192. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,176
Previous 2,504
66.77%
Holding current value
$906,192
Previous $701,000
26.39%
% of portfolio
0.1%
Previous 0.1%
Shares
14 transactions
Others Institutions Holding MDGL
# of Institutions
299Shares Held
22MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$539 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$446 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$428 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$416 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$401 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $3.71B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...